In a trial for sufferers with relapsed or refractory mantle cell lymphoma, 85.3% of sufferers responded after remedy with Breyanzi. Remedy with CAR-T...
In a trial, 80% of sufferers with Waldenstrom’s macroglobulinemia confirmed responses to remedy after receiving the novel iopofosine I 131.A novel drug, iopofosine...
